Eric Nguyen, Radical Numerics CEO on AI for Biological Intelligence

Eric Nguyen is the Co-Founder and CEO of Radical Numerics, an AI research lab building general biological intelligence—next-generation foundation models that can reason across DNA, RNA, proteins, and other biological data to accelerate breakthroughs in healthcare, biotechnology, and biosecurity. ~~~~~~~~~~~~~This episode is brought to you by Nebius — the ultimate cloud for AI innovators.Nebius provides AI infrastructure you can count on, combining reliability and speed with flexibility and engineering support unmatched by hyperscalers.AI leaders like Meta, Shopify, and Higgsfield already partner with Nebius to run their AI workloads. Plus, venture-backed startups can save up to $150,000 on compute costs when they apply for access. Visit nebius.com or nebius.com/startups to learn more~~~~~~~~~~~~~The company launched with $50 million in seed funding led by Emergence Capital and is pioneering multimodal AI systems capable of reading, writing, and designing biology while embedding safety and biosecurity into the foundation of its models. Before founding Radical Numerics, Eric earned his Ph.D. in Bioengineering and AI from Stanford University, where he helped pioneer the emerging field of generative genomics. He and his team created Evo, the first large language model capable of generating DNA at scale and one of the largest open-source biological AI projects ever released, followed by Evo 2, which advanced AI's ability to model and engineer biological systems. Today, Radical Numerics is applying these advances to cancer diagnostics, drug discovery, and next-generation therapeutics while developing AI systems that can identify AI-generated pathogens and strengthen global biodefense. Eric's work sits at the intersection of frontier AI, biology, and responsible innovation, helping define how artificial intelligence will transform the life sciences.TopicsThe future of AI in biology: building foundation models that can read, write, and design living systemsFrom generative genomics to general biological intelligence: how multimodal AI will transform drug discovery, diagnostics, and healthcareBuilding frontier AI responsibly: balancing scientific breakthroughs, biosecurity, and the safe development of biological intelligence#ArtificialIntelligence #Biotech #HealthcareAI #GenerativeAI #LifeSciences